Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM - PubMed (original) (raw)
Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM
T Utriainen et al. Diabetologia. 1998 May.
Abstract
Skeletal muscle insulin resistance and coronary heart disease (CHD) often precede non-insulin-dependent diabetes mellitus (NIDDM). A recent study showed the myocardium of patients with CHD to be insulin resistant, independent of blood flow. We determined whether myocardial insulin resistance is a feature of NIDDM patients with no CHD. Skeletal muscle and myocardial glucose uptake were determined in 10 patients with NIDDM and 9 age- and weight-matched normal men of similar age and body mass index men using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography under normoglycaemic hyperinsulinaemic conditions. Whole body glucose uptake, as determined by the euglycaemic clamp technique, was significantly lower in the patients with NIDDM (35+/-3 micromol/kg body weight min) than the normal subjects (45+/-3 micromol/kg body weight x min, p < 0.02). Insulin-stimulated femoral muscle glucose uptake was significantly lower in the patients with NIDDM (71+/-6 micromol/kg muscle x min) than in the normal subjects (96+/-5 micromol/kg muscle x min, p < 0.01). Whole body glucose uptake was correlated with femoral muscle glucose uptake in the entire group (r=0.76, p < 0.001), in patients with NIDDM and in normal subjects. Rates of insulin-stimulated myocardial glucose uptake were comparable between the patients with NIDDM (814+/-76 micromol/kg muscle min) and the normal subjects (731+/-63 micromol/kg muscle min, p > 0.4). Whole body or femoral muscle, and myocardial glucose uptake were not correlated in all subjects, patients with NIDDM or normal subjects. We conclude that insulin resistance of the myocardium is not a feature of uncomplicated NIDDM.
Similar articles
- Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.
Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, Radda GK, Ferrannini E. Paternostro G, et al. J Clin Invest. 1996 Nov 1;98(9):2094-9. doi: 10.1172/JCI119015. J Clin Invest. 1996. PMID: 8903329 Free PMC article. - Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.
Utriainen T, Nuutila P, Takala T, Vicini P, Ruotsalainen U, Rönnemaa T, Tolvanen T, Raitakari M, Haaparanta M, Kirvelä O, Cobelli C, Yki-Järvinen H. Utriainen T, et al. J Clin Invest. 1997 Aug 15;100(4):777-85. doi: 10.1172/JCI119591. J Clin Invest. 1997. PMID: 9259575 Free PMC article. - Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, Haaparanta M, Knuuti J, Nuutila P. Laine H, et al. J Clin Invest. 1998 Mar 1;101(5):1156-62. doi: 10.1172/JCI1065. J Clin Invest. 1998. PMID: 9486987 Free PMC article. Clinical Trial. - Metabolic aspects of insulin resistance in individuals born small for gestational age.
Vaag A, Jensen CB, Poulsen P, Brøns C, Pilgaard K, Grunnet L, Vielwerth S, Alibegovic A. Vaag A, et al. Horm Res. 2006;65 Suppl 3:137-43. doi: 10.1159/000091519. Epub 2006 Apr 10. Horm Res. 2006. PMID: 16612127 Review.
Cited by
- Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy.
Elnwasany A, Ewida HA, Szweda PA, Szweda LI. Elnwasany A, et al. Antioxidants (Basel). 2023 Mar 20;12(3):756. doi: 10.3390/antiox12030756. Antioxidants (Basel). 2023. PMID: 36979003 Free PMC article. Review. - Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges.
Nicholson TA, Sagmeister M, Wijesinghe SN, Farah H, Hardy RS, Jones SW. Nicholson TA, et al. Pharmaceutics. 2023 Jan 10;15(1):237. doi: 10.3390/pharmaceutics15010237. Pharmaceutics. 2023. PMID: 36678864 Free PMC article. Review. - Regenerating islet-derived protein 3α: A promising therapy for diabetes. Preliminary data in rodents and in humans.
Le Lay A, Philippe E, Roth F, Sanchez-Archidona AR, Mehl F, Denom J, Prasad R, Asplund O, Hansson O, Ibberson M, Andreelli F, Santoro L, Amouyal P, Amouyal G, Brechot C, Jamot L, Cruciani-Guglielmacci C, Magnan C. Le Lay A, et al. Heliyon. 2022 Jul 16;8(7):e09944. doi: 10.1016/j.heliyon.2022.e09944. eCollection 2022 Jul. Heliyon. 2022. PMID: 35874080 Free PMC article. - Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study.
Succurro E, Vizza P, Papa A, Cicone F, Monea G, Tradigo G, Fiorentino TV, Perticone M, Guzzi PH, Sciacqua A, Andreozzi F, Veltri P, Cascini GL, Sesti G. Succurro E, et al. Front Cardiovasc Med. 2022 Jun 29;9:924787. doi: 10.3389/fcvm.2022.924787. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35845046 Free PMC article. - Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review).
Wang W, Zhong X, Guo J. Wang W, et al. Int J Mol Med. 2021 Jun;47(6):114. doi: 10.3892/ijmm.2021.4947. Epub 2021 Apr 28. Int J Mol Med. 2021. PMID: 33907839 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical